Morphine Sulfate Extended Release NDC 72162-1352

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1352Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1352Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1352-1	72162135201	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1352-1)Marketed from Apr 3, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Morphine Sulfate Extended ReleaseSuffix: Extended Release
Generic name (nonproprietary): morphine sulfate
Active ingredients: Morphine sulfate — 200 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074769
Marketing start: Jan 14, 2011
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Full Opioid Agonists (Mechanism)
Identifiers: Product ID 72162-1352_3142315d-d688-405d-962a-c684f7e6e7a6SPL ID 3142315d-d688-405d-962a-c684f7e6e7a6SPL set ID c94d9da6-7a12-44ee-a38f-3323ee27842cRxCUI 892646UNII X3P646A2J0
Pharmacologic class: Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162135201 followed by a unit qualifier and the quantity

Package 72162-1352-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 3, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Morphine sulfate extended-release tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Morphine sulfate extended-release tablets are an opioid agonist indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074769

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074769
Product	Strength	Form · route	Labeler	Product NDC
Morphine Sulfate Extended Releasemorphine sulfate	Morphine sulfate 100 mg/1	Tablet, Film coated, Extended releaseOral	Major Pharmaceuticals	0904-6560
Morphine Sulfate Extended Releasemorphine sulfate	Morphine sulfate 200 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	63629-8505
Morphine Sulfate Extended Releasemorphine sulfate	Morphine sulfate 100 mg/1	Tablet, Film coated, Extended releaseOral	Rhodes Pharmaceuticals LLC	42858-804
Morphine Sulfate Extended Releasemorphine sulfate	Morphine sulfate 200 mg/1	Tablet, Film coated, Extended releaseOral	Rhodes Pharmaceuticals LLC	42858-805